Steph Sherer, Founder and President of Americans for Safe Access (ASA), discusses the prevalence, challenges and treatments for chronic pain management.
Lorenza Romanese, Managing Director of the European Industrial Hemp Association (EIHA) examines the future of hemp and explains in this vein, what is at stake, as well as looking back at its fascinating history.
Cosmo Feilding Mellen, Managing Director of Spectrum Therapeutics UK looks at access to medical cannabis and to what extent is medical cannabis now legalised.
John Wallace, Managing Director of Mile High Labs, International, shares with us why CBD continues to be one of the most exciting new products to hit the marketplace and focuses here on some significant numbers in the field.
CBD has been gaining popularity over recent years, with a wide range of CBD infused products available to buy on the high street, but what is it, and can it really help?.
Here, General Manager Bart den Hertog, introduces MariPharm, the world’s first medicinal cannabis business, highlighting the company’s major milestone moments, its clinical trial process and recommended product dosage.
BioBloom has specialised in the production of high-quality organic hemp products with absolutely no additives since 2016. The production focuses on the preservation of all valuable ingredients of the hemp plant.
Professor Mike Barnes, Director of Education at The Academy of Medical Cannabis shares his thoughts on the rescheduling of cannabis to a Schedule II substance in November of 2018 and access to medical cannabis prescriptions.
